Metraipolis › archive › dc_5ceeea96d5c8

CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier — Europe PMC PMID:41608436

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41608436
DOI
10.3389/fmed.2025.1731589
License (as archived)
solo-consultazione
Archived
2026-11-06T20:35:52.617Z
SHA-256 of the archived text
0dd2229744ae7a5b6fa939c759029146556f9c71cffb7150a1dbfd4d94bc182a
Stable URL of this page
https://metraipolis.com/documento/dc_5ceeea96d5c8

How to cite

CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier — Europe PMC PMID:41608436 — Europe PMC (en), https://europepmc.org/article/MED/41608436 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ceeea96d5c8 (Metraipolis archive dc_5ceeea96d5c8, sha256 0dd2229744ae7a5b6fa939c759029146556f9c71cffb7150a1dbfd4d94bc182a)
BibTeX
@misc{dc5ceeea96d5c8,
  title = {CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier — Europe PMC PMID:41608436},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41608436},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ceeea96d5c8; sha256 0dd2229744ae7a5b6fa939c759029146556f9c71cffb7150a1dbfd4d94bc182a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608436. Agents can read the archived copy with the MCP tool read_document.